BioSpace News Archive

EicOsis Human Health, located in Davis, CA, recently received a $5 million dollar investment from Open Philanthropy to support clinical trials on a novel, non-opioid, oral therapy for neuropathic and inflammatory pain.

Less Invasive Evolut(TM) Transcatheter Aortic Valve Replacement (TAVR) System Successful in Clinical Trial When Compared to Open Heart Surgery in Healthier Aortic Stenosis Patients

Vejthani Hospital, one of the leading hospitals specializing in bone and joint treatment in Thailand, called on patients suffering from complications caused by diseases such as diabetes to regularly care for their health and practice self-monitoring, including taking care of their wounds and checking their nervous system, to prevent the occurrence of Charcot foot.

WRAP-IT is the Largest Randomized Global Trial Ever Conducted with Cardiac Implanted Electronic Devices

PhaseBio Pharmaceuticals, Inc. announced that results from the Phase 1 clinical trial of PB2452, a novel reversal agent for the antiplatelet drug ticagrelor, demonstrated that PB2452 provided immediate and sustained reversal of ticagrelor antiplatelet effects without report of drug-related serious adverse events.

SelectMDx demonstrates accurate identification of both low-risk and aggressive prostate cancer across all patient groups

The Nomination Committee has consisted of Axel Calissendorff, Chairman of the nomination committee, Lars Backsell, Johan Lannebo and Ossian Ekdahl.

TLC announced that the first patient has been dosed a Phase II clinical trial for TLC590 following bunionectomy.

CytoDyn Inc., a late stage biotechnology company developing leronlimab, a CCR5 antagonist with the potential for multiple therapeutic indications, today announced that it has filed with the U.S. Food and Drug Administration the non-clinical portion of its Biologics License Application using the FDA’s Rolling Review process.

Soligenix, Inc. announced that they will be presenting at the National Institutes of Health - Commercialization Accelerator Program “FeedForward Session” in Washington, DC on March 21, 2019.